Antimalarial Resistance Unlikely To Explain UK Artemether-Lumefantrine Failures

被引：1
|
作者：
van der Pluijm, Rob W. [1 ]
Watson, James [1 ]
Woodrow, Charles J. [1 ]
机构：
[1] Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2017年 / 61卷 / 07期
关键词：
artemether; failure; falciparum; lumefantrine; malaria; recrudescence; resistance; PLASMODIUM-FALCIPARUM MALARIA; ARTEMISININ RESISTANCE; EFFICACY; SAFETY;
D O I：
10.1128/AAC.00721-17
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Reply to van der Pluijm et al., "Antimalarial Resistance Unlikely To Explain UK Artemether-Lumefantrine Failures"
    Sutherland, Colin J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (07)
  • [2] Artemether-lumefantrine: an oral antimalarial for uncomplicated malaria in children
    Adjei, George O.
    Goka, Bamenla Q.
    Binka, Fred
    Kurtzhals, Jorgen A. L.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (06) : 669 - 681
  • [3] No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine
    van Vugt, M
    Ezzet, F
    Nosten, F
    Gathmann, I
    Wilairatana, P
    Looareesuwan, S
    White, NJ
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 61 (06): : 964 - 967
  • [4] ARTEMETHER-LUMEFANTRINE ANTIMALARIAL EFFICACY AMONG ADULTS ON ANTIRETROVIRAL THERAPY IN MALAWI
    Miller, Jernelle C.
    Nyangulu, Wongani
    Mungwira, Randy G.
    Divala, Titus H.
    Nampota, Nginache
    Parikh, Sunil
    Oosterhout, Joep J.
    Laurens, Matthew B.
    Laufer, Miriam K.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 227 - 227
  • [5] Artemether-Lumefantrine: An Option for Malaria
    Stover, Kayla R.
    King, S. Travis
    Robinson, Jessica
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (04) : 567 - 577
  • [6] Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children
    Huang, Liusheng
    Carey, Vincent
    Lindsey, Jane C.
    Marzan, Florence
    Gingrich, David
    Graham, Bobbie
    Barlow-Mosha, Linda
    Ssemambo, Phionah K.
    Kamthunzi, Portia
    Nachman, Sharon
    Parikh, Sunil
    Aweeka, Francesca T.
    PLOS ONE, 2017, 12 (10):
  • [7] Enhanced Antimalarial Activity by a Novel Artemether-Lumefantrine Lipid Emulsion for Parenteral Administration
    Ma, Yufan
    Lu, Tingli
    Zhao, Wen
    Wang, Ying
    Chen, Ting
    Mei, Qibing
    Chen, Tao
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (10) : 5658 - 5665
  • [8] Desbutyl-Lumefantrine Is a Metabolite of Lumefantrine with Potent In Vitro Antimalarial Activity That May Influence Artemether-Lumefantrine Treatment Outcome
    Wong, Rina P. M.
    Salman, Sam
    Ilett, Kenneth F.
    Siba, Peter M.
    Mueller, Ivo
    Davis, Timothy M. E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (03) : 1194 - 1198
  • [9] The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine
    Djimde, Abdoulaye A.
    Makanga, Michael
    Kuhen, Kelli
    Hamed, Kamal
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (08) : 1031 - 1045
  • [10] Alternative form of artemether-lumefantrine for infants
    Teklehaimanot, Awash
    Teklehaimanot, Hailay Desta
    LANCET, 2008, 372 (9652): : 1786 - 1787
12345